Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France flag France · Delayed Price · Currency is EUR
0.2410
-0.0110 (-4.37%)
Last updated: Nov 11, 2026, 10:48 AM CET

EPA:ALOPM Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Revenue
0.230.260.211.077.98
Other Revenue
1.571.551.420.340.27
1.81.811.621.418.25
Revenue Growth
3.65%11.66%14.90%-82.88%-
Cost of Revenue
5.39-6.946.5187.56
Gross Profit
-3.598.75-4.89-6.580.69
Selling, General & Admin
1.962.592.593.312.08
Other Operating Expenses
0.290.110.07-0.210.06
Operating Expenses
2.663.052.923.362.3
Operating Income
-6.255.71-7.81-9.94-1.61
Interest Expense
-0.15-0.19-0.44-0.15-0.12
Interest & Investment Income
0.060.050.30.240
Currency Exchange Gain (Loss)
-0-0-0-0.020
Other Non Operating Income (Expenses)
-0.01-0.02--0
EBT Excluding Unusual Items
-6.355.55-7.95-9.86-1.72
Gain (Loss) on Sale of Investments
0-0.04-0.020.01-
Other Unusual Items
00-0.350-0
Pretax Income
-6.345.51-8.31-9.85-1.72
Income Tax Expense
0.070.03-1.1-1.76-1.49
Net Income
-6.415.48-7.21-8.09-0.23
Net Income to Common
-6.415.48-7.21-8.09-0.23
Net Income Growth
-----
Shares Outstanding (Basic)
1918181717
Shares Outstanding (Diluted)
1918181717
Shares Change
3.28%1.34%9.16%-0.48%-
EPS (Basic)
-0.340.30-0.40-0.49-0.01
EPS (Diluted)
-0.340.30-0.40-0.49-0.01
EPS Growth
-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
-199.37%482.81%--8.39%
Operating Margin
-346.94%314.83%-480.86%-703.75%-19.51%
Profit Margin
-355.69%302.27%-444.06%-572.60%-2.80%
EBITDA
-5.836.05-7.55-9.69-1.45
EBITDA Margin
-333.58%---17.52%
D&A For EBITDA
0.420.340.260.250.16
EBIT
-6.255.71-7.81-9.94-1.61
EBIT Margin
-314.83%---19.51%
Effective Tax Rate
-0.61%---
Revenue as Reported
1.821.811.641.758.32